Discussing recent FDA-approvals of pembrolizumab for metastatic or unresectable, recurrent Head & Neck Cancer (1st line) and Small Cell Lung Cancer (3rd line)
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
